ANTHONY ALVAREZ: Open Payments
NPI 1407856057 · ERLANGER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,474 in 55 payments from 12 companies in 2025. Trend: 2023 $2,750 · 2024 $2,478 · 2025 $2,474
Food & beverage: $2,474
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $582 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $486 |
| ABBVIE INC. | 8 | $420 |
| Axsome Therapeutics, Inc. | 5 | $274 |
| Teva Pharmaceuticals USA, Inc. | 10 | $268 |
| Luye Pharma (USA) Ltd. | 4 | $184 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $98 |
| Noven Therapeutics, LLC | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Indivior Inc. | 1 | $25 |
Products named: CAPLYTA, VRAYLAR, ABILIFY MAINTENA, Auvelity, REXULTI, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE, LUMRYZ.
Industry payments across KY — which companies pay providers there.
